Penumbra Q2 revenue $184.3M (+75.3% YoY); raises FY2021 guidance to $720-730M

Penumbra Inc

2021-Q2 EPS reported $0.56 revenue$353,462,000

Revenue $184.3M (+75.3% YoY); vascular $100.7M (+117.6%), neuro $83.6M (+42.0%).
Operating income of $10.3M vs. operating loss of $17.6M in Q2 2020.
Gross margin improved to 64.4% from 61.8%.
Full-year 2021 revenue guidance raised to $720-730M from $695-705M (28-30% growth).
No EPS figure provided in release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.